Tetsuzo Tauchi

4.4k total citations
146 papers, 3.1k citations indexed

About

Tetsuzo Tauchi is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tetsuzo Tauchi has authored 146 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Hematology, 72 papers in Genetics and 53 papers in Molecular Biology. Recurrent topics in Tetsuzo Tauchi's work include Chronic Myeloid Leukemia Treatments (81 papers), Chronic Lymphocytic Leukemia Research (59 papers) and Acute Myeloid Leukemia Research (29 papers). Tetsuzo Tauchi is often cited by papers focused on Chronic Myeloid Leukemia Treatments (81 papers), Chronic Lymphocytic Leukemia Research (59 papers) and Acute Myeloid Leukemia Research (29 papers). Tetsuzo Tauchi collaborates with scholars based in Japan, United States and France. Tetsuzo Tauchi's co-authors include Kazuma Ohyashiki, Junko H. Ohyashiki, Seiichi Okabe, Goro Sashida, Masahiko Sumi, Keisuke Miyazawa, Hal E. Broxmeyer, Akihiro Nakajima, H. Scott Boswell and Kazuo Shin‐ya and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Tetsuzo Tauchi

140 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tetsuzo Tauchi Japan 30 1.6k 1.5k 911 621 442 146 3.1k
Matthias Mayerhofer Austria 32 1.3k 0.8× 1.1k 0.7× 820 0.9× 446 0.7× 1.3k 2.9× 75 3.2k
A Strife United States 30 1.2k 0.7× 1.3k 0.9× 780 0.9× 544 0.9× 501 1.1× 59 2.7k
Keiko Okuda Japan 24 949 0.6× 1.2k 0.8× 747 0.8× 651 1.0× 717 1.6× 67 2.6k
Keita Kirito Japan 29 1.2k 0.7× 1.1k 0.7× 585 0.6× 433 0.7× 375 0.8× 128 2.3k
Sabine Cerny‐Reiterer Austria 29 808 0.5× 849 0.6× 576 0.6× 453 0.7× 692 1.6× 65 2.2k
Véronique Mansat‐De Mas France 25 1.3k 0.8× 1.4k 0.9× 546 0.6× 428 0.7× 358 0.8× 57 2.5k
Goro Sashida Japan 28 2.0k 1.2× 1.1k 0.7× 404 0.4× 390 0.6× 287 0.6× 88 2.7k
Dario Ferrero Italy 25 872 0.6× 1.0k 0.7× 488 0.5× 472 0.8× 338 0.8× 92 2.0k
Sophie Park France 26 1.4k 0.9× 1.3k 0.8× 721 0.8× 385 0.6× 252 0.6× 93 2.6k
Masayuki Towatari Japan 27 1.7k 1.1× 1.6k 1.0× 595 0.7× 570 0.9× 433 1.0× 40 2.9k

Countries citing papers authored by Tetsuzo Tauchi

Since Specialization
Citations

This map shows the geographic impact of Tetsuzo Tauchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuzo Tauchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuzo Tauchi more than expected).

Fields of papers citing papers by Tetsuzo Tauchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuzo Tauchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuzo Tauchi. The network helps show where Tetsuzo Tauchi may publish in the future.

Co-authorship network of co-authors of Tetsuzo Tauchi

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuzo Tauchi. A scholar is included among the top collaborators of Tetsuzo Tauchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuzo Tauchi. Tetsuzo Tauchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cortes, Jörge E., Hervé Dombret, Akil Merchant, et al.. (2019). Glasdegib Plus Intensive/Nonintensive Chemotherapy in Untreated Acute Myeloid Leukemia: BRIGHT AML 1019 Phase III Trials. Future Oncology. 15(31). 3531–3545. 38 indexed citations
2.
Okabe, Seiichi, Yuko Tanaka, Tetsuzo Tauchi, & Kazuma Ohyashiki. (2018). Copanlisib, a novel phosphoinositide 3-kinase inhibitor, combined with carfilzomib inhibits multiple myeloma cell proliferation. Annals of Hematology. 98(3). 723–733. 15 indexed citations
3.
Tanaka, Yuko, Seiichi Okabe, Tetsuzo Tauchi, Yoshikazu Ito, & Kazuma Ohyashiki. (2018). Targeting Insulin-like Growth Factor in Multiple Myeloma: Novel Strategies in the Treatment of Proteasome Inhibitor Resistant Cells. Blood. 132(Supplement 1). 5155–5155. 1 indexed citations
4.
Okabe, Seiichi, Tetsuzo Tauchi, Yuko Tanaka, & Kazuma Ohyashiki. (2017). Peroxisome Proliferator-Activated Receptors: Targets for the Treatment of Philadelphia Chromosome-Positive Leukemia Cells. Blood. 130. 5241–5241. 1 indexed citations
5.
Tauchi, Tetsuzo, Seiichi Okabe, Seiichiro Katagiri, Yuko Tanaka, & Kazuma Ohyashiki. (2017). Combining Effects of the SMO Inhibitor and BCL-2 Inhibitor in MDS-Derived Induced Potent Stem Cells (iPSC). Blood. 130. 1249–1249. 3 indexed citations
6.
Okabe, Seiichi, Tetsuzo Tauchi, Yuko Tanaka, & Kazuma Ohyashiki. (2016). Anti-Leukemic Effects of Venetoclax on Philadelphia Chromosome Positive Leukemia Cells. Blood. 128(22). 5428–5428. 8 indexed citations
7.
Gotoh, Moritaka, Seiichiro Yoshizawa, Seiichiro Katagiri, et al.. (2014). Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2–4 acute graft‐versus‐host disease. Transplant Infectious Disease. 16(3). 440–449. 22 indexed citations
8.
Katagiri, Seiichiro, Tetsuzo Tauchi, Seiichi Okabe, et al.. (2013). Combination of Ponatinib with Hedgehog Antagonist Vismodegib for Therapy-Resistant BCR-ABL1–Positive Leukemia. Clinical Cancer Research. 19(6). 1422–1432. 35 indexed citations
9.
Okabe, Seiichi, Tetsuzo Tauchi, Yuko Tanaka, Seiichiro Katagiri, & Kazuma Ohyashiki. (2012). Effects of the Hedgehog Inhibitor GDC-0449, Alone or in Combination with Dasatinib, on BCR-ABL-Positive Leukemia Cells. Stem Cells and Development. 21(16). 2939–2948. 16 indexed citations
10.
Okabe, Seiichi, Tetsuzo Tauchi, Akihiro Nakajima, et al.. (2007). Depsipeptide (FK228) Preferentially Induces Apoptosis in BCR/ABL-Expressing Cell Lines and Cells from Patients with Chronic Myelogenous Leukemia in Blast Crisis. Stem Cells and Development. 16(3). 503–514. 29 indexed citations
11.
Tauchi, Tetsuzo, Junko H. Ohyashiki, & Kazuma Ohyashiki. (2007). Telomerase Inhibition Combined with Other Chemotherapeutic Reagents to Enhance Anti-Cancer Effect. Methods in molecular biology. 405. 181–189. 6 indexed citations
12.
Tauchi, Tetsuzo & Kazuma Ohyashiki. (2004). Imatinib Mesylate in Combination with Other Chemotherapeutic Agents for Chronic Myelogenous Leukemia. International Journal of Hematology. 79(5). 434–440. 6 indexed citations
13.
Sumi, Masahiko, Tetsuzo Tauchi, Takashi Shimamoto, et al.. (2002). [Chronic myeloid leukemia associated with sustained severe pancytopenia after imatinib mesylate therapy].. PubMed. 43(9). 868–70. 8 indexed citations
14.
Kawanishi, Y, Kazuya Ando, Hiroshi Iwama, et al.. (2000). [Rapidly progressive fibrosis and increased CD68-positive cells in the bone marrow at the terminal stage of adult T-cell leukemia accompanied by polycythemia vera].. PubMed. 41(12). 1254–9. 2 indexed citations
15.
Ito, Yumi, et al.. (1999). A patient with pure red cell aplasia and Good's syndrome.. PubMed. 84(11). 1048–9. 8 indexed citations
16.
Nakatani, Satoshi, et al.. (1998). [A case report of epidural abscess due to anaerobic bacteria, producing a mass of gas].. PubMed. 38(3). 224–7. 4 indexed citations
17.
Tauchi, Tetsuzo, H. Scott Boswell, D Leibowitz, & H E Broxmeyer. (1994). Coupling between p210bcr-abl and Shc and Grb2 adaptor proteins in hematopoietic cells permits growth factor receptor-independent link to ras activation pathway.. The Journal of Experimental Medicine. 179(1). 167–175. 115 indexed citations
18.
Kawakubo, Ken, Junko H. Ohyashiki, Kazuma Ohyashiki, et al.. (1994). Hypomethylated status, but not RAG-1, is required for T-cell receptor-β-chain gene rearrangement in acute leukemia cells. Cancer Genetics and Cytogenetics. 78(1). 40–45. 7 indexed citations
19.
Ohyashiki, Kazuma, et al.. (1990). ETS1 gene in myelodysplastic syndrome with chromosome change at 11q23. Cancer Genetics and Cytogenetics. 45(1). 73–80. 5 indexed citations
20.
Ohyashiki, Kazuma, et al.. (1990). Philadelphia Chromosome‐positive Chronic Myelogenous Leukemia with Deleted Fusion of BCR and ABL Genes. Japanese Journal of Cancer Research. 81(1). 35–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias Mayerhofer Breakdown of academic impact, for papers by A Strife Breakdown of academic impact, for papers by Keiko Okuda Breakdown of academic impact, for papers by Keita Kirito Breakdown of academic impact, for papers by Sabine Cerny‐Reiterer Breakdown of academic impact, for papers by Véronique Mansat‐De Mas Breakdown of academic impact, for papers by Goro Sashida Breakdown of academic impact, for papers by Dario Ferrero Breakdown of academic impact, for papers by Sophie Park Breakdown of academic impact, for papers by Masayuki Towatari
Rankless by CCL
2026